Orgenesis Inc. (NASDAQ: ORGS)
$0.71
+0.0099 ( +1.41% ) 38.6K
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.
Market Data
Open
$0.71
Previous close
$0.70
Volume
38.6K
Market cap
$33.05M
Day range
$0.70 - $0.74
52 week range
$0.25 - $1.31
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
nt | Quarterly Reports | 1 | Apr 01, 2024 |
8-k | 8K-related | 13 | Mar 27, 2024 |
8-k | 8K-related | 19 | Mar 07, 2024 |
8-k | 8K-related | 15 | Mar 01, 2024 |
4 | Insider transactions | 1 | Feb 14, 2024 |
4 | Insider transactions | 1 | Feb 14, 2024 |
8-k | 8K-related | 15 | Jan 31, 2024 |
8-k | 8K-related | 13 | Jan 24, 2024 |
8-k | 8K-related | 13 | Jan 22, 2024 |
3 | Insider transactions | 1 | Jan 08, 2024 |